UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug resistance in liver flukes

International journal for parasitology -- drugs and drug resistance, 2020-04, Vol.12, p.39-59

2020

Volltextzugriff (PDF)

Recent developments in the epidemiology, diagnosis, and treatment of Fasciola infection

Current opinion in infectious diseases, 2018-10, Vol.31 (5), p.409-414

2018

Volltextzugriff (PDF)

A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance

PLoS pathogens, 2023-01, Vol.19 (1), p.e1011081

2023

Volltextzugriff (PDF)

Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide

PLoS neglected tropical diseases, 2013-11, Vol.7 (11), p.e2553-e2553

2013

Volltextzugriff (PDF)

Anthelmintic effects of some medicinal plants on different life stages of Fasciola hepatica: Evidence on oxidative stress biomarkers, and DNA damage

PLoS neglected tropical diseases, 2024-06, Vol.18 (6), p.e0012251

2024

Volltextzugriff (PDF)

Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series

PLoS neglected tropical diseases, 2016-01, Vol.10 (1), p.e0004361-e0004361

2016

Volltextzugriff (PDF)

Pilot Evaluation of Two Fasciola hepatica Biomarkers for Supporting Triclabendazole (TCBZ) Efficacy Diagnostics

Molecules (Basel, Switzerland), 2020-07, Vol.25 (15), p.3477

2020

Volltextzugriff (PDF)

An Outbreak of Human Fascioliasis gigantica in Southwest China

PloS one, 2013-08, Vol.8 (8), p.e71520-e71520

2013

Volltextzugriff (PDF)

Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis

Current opinion in infectious diseases, 2008-10, Vol.21 (5), p.523-530

2008

Volltextzugriff (PDF)

Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity

Scientific reports, 2020-02, Vol.10 (1), p.2587-2587, Article 2587

2020

Volltextzugriff (PDF)

Human fascioliasis in Argentina: retrospective overview, critical analysis and baseline for future research

Parasites & vectors, 2011-06, Vol.4 (1), p.104-104, Article 104

2011

Volltextzugriff (PDF)

Efficacy of flukicides against Fasciola hepatica and first report of triclabendazole resistance on German sheep farms

International journal for parasitology -- drugs and drug resistance, 2023-12, Vol.23, p.94-105

2023

Volltextzugriff (PDF)

Improving animal and human health through understanding liver fluke immunology

Parasite immunology, 2010-08, Vol.32 (8), p.572-581

2010

Volltextzugriff (PDF)

First report of closantel treatment failure against Fasciola hepatica in cattle

International journal for parasitology -- drugs and drug resistance, 2015-12, Vol.5 (3), p.172-177

2015

Volltextzugriff (PDF)

The anti-fasciolasis properties of silver nanoparticles produced by Trichoderma harzianum and their improvement of the anti-fasciolasis drug triclabendazole

International journal of molecular sciences, 2013-11, Vol.14 (11), p.21887-21898

2013

Volltextzugriff (PDF)

Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano

PLoS neglected tropical diseases, 2012-08, Vol.6 (8), p.e1720

2012

Volltextzugriff (PDF)

Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt

PLoS neglected tropical diseases, 2019-09, Vol.13 (9), p.e0007779-e0007779

2019

Volltextzugriff (PDF)

Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica

Scientific reports, 2020-08, Vol.10 (1), p.13445, Article 13445

2020

Volltextzugriff (PDF)

Diagnosis of human fascioliasis in Arusha region, northern Tanzania by microscopy and clinical manifestations in patients

BMC infectious diseases, 2015-12, Vol.15 (577), p.578-578, Article 578

2015

Volltextzugriff (PDF)

Integrating fasciolosis control in the dry cow management: the effect of closantel treatment on milk production

PloS one, 2012-08, Vol.7 (8), p.e43216

2012

Volltextzugriff (PDF)

Evaluating the effectiveness of trematocides against Fasciola gigantica and amphistomes infections in cattle, using faecal egg count reduction tests in Iringa Rural and Arumeru Districts, Tanzania

Parasites & vectors, 2018-07, Vol.11 (1), p.384-384, Article 384

2018

Volltextzugriff (PDF)

Insights into the Interactions of Fasciola hepatica Cathepsin L3 with a Substrate and Potential Novel Inhibitors through In Silico Approaches

PLoS neglected tropical diseases, 2015-05, Vol.9 (5), p.e0003759-e0003759

2015

Volltextzugriff (PDF)

Microscopic alterations in Fasciola hepatica from sheep treated with albendazole

Revista brasileira de parasitologia veterinaria, 2019-01, Vol.28 (1), p.33-39

2019

Volltextzugriff (PDF)

New developments in epidemiology, diagnosis, and treatment of fascioliasis

Current opinion in infectious diseases, 2012-10, Vol.25 (5), p.518-522

2012

Volltextzugriff (PDF)

Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study

BMC cancer, 2015-10, Vol.15 (1), p.776-776, Article 776

2015

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(81)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug resistance in liver flukes

Recent developments in the epidemiology, diagnosis, and treatment of Fasciola infection

A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance

Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide

Anthelmintic effects of some medicinal plants on different life stages of Fasciola hepatica: Evidence on oxidative stress biomarkers, and DNA damage

Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series

Pilot Evaluation of Two Fasciola hepatica Biomarkers for Supporting Triclabendazole (TCBZ) Efficacy Diagnostics

An Outbreak of Human Fascioliasis gigantica in Southwest China

Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis

Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity

Human fascioliasis in Argentina: retrospective overview, critical analysis and baseline for future research

Efficacy of flukicides against Fasciola hepatica and first report of triclabendazole resistance on German sheep farms

Improving animal and human health through understanding liver fluke immunology

First report of closantel treatment failure against Fasciola hepatica in cattle

The anti-fasciolasis properties of silver nanoparticles produced by Trichoderma harzianum and their improvement of the anti-fasciolasis drug triclabendazole

Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano

Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt

Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica

Diagnosis of human fascioliasis in Arusha region, northern Tanzania by microscopy and clinical manifestations in patients

Integrating fasciolosis control in the dry cow management: the effect of closantel treatment on milk production

Evaluating the effectiveness of trematocides against Fasciola gigantica and amphistomes infections in cattle, using faecal egg count reduction tests in Iringa Rural and Arumeru Districts, Tanzania

Insights into the Interactions of Fasciola hepatica Cathepsin L3 with a Substrate and Potential Novel Inhibitors through In Silico Approaches

Microscopic alterations in Fasciola hepatica from sheep treated with albendazole

New developments in epidemiology, diagnosis, and treatment of fascioliasis

Association between praziquantel treatment and cholangiocarcinoma: a hospital-based matched case-control study

Aktive Filter

Suchergebnisse filtern